Dexcom Inc. Aktie
129,08 €
Deine Einschätzung
Dexcom Inc. Aktie
Was spricht für und gegen Dexcom Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Dexcom Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Dexcom Inc. | 0,17 % | 6,20 % | 21,18 % | 19,85 % | 15,09 % | 72,22 % | 405,58 % |
Baxter International | -0,51 % | 2,07 % | 2,20 % | 6,26 % | 12,55 % | -45,85 % | -43,97 % |
Dentsply Sirona Inc. | -1,29 % | 1,44 % | -0,58 % | -11,16 % | -3,98 % | -40,53 % | -29,61 % |
Zimmer Holdings | 0,24 % | 2,83 % | 1,29 % | 1,17 % | 7,32 % | -13,83 % | 5,23 % |
Kommentare
News
2 Medical Device Stocks to Buy Hand Over Fist in March
A good way to invest in the healthcare industry's continued growth is by targeting businesses that make medical devices. Such equipment aids physicians in surgery, helps patients recover, and can
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical evidence supporting the use of Dexcom